project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN1; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.87; rna integrity number: 10.0; age at index: 75; days to birth: -27687; days to death: 941; ethnicity: not hispanic or latino; gender: female; race: not reported; vital status: Dead; year of birth: 1931; year of death: 2008; age at diagnosis: 27687; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.5753424657534247; pack years smoked: 47.0; is ffpe: false; composition: Not Reported; days to collection: 2644; days to sample procurement: 0; initial weight: 710.0; portion submitter id: TCGA-XF-AAN1-01A-31; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 0.0; percent necrosis: 4.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 18.0; percent tumor cells: 78.0; percent tumor nuclei: 90.0;